Lucinactant for Inhalation
03-CL-1702
Phase 2 other terminated
Quick answer
Lucinactant for Inhalation for Respiratory Distress Syndrome, Newborn is a Phase 2 program (other) at WINDTREE THERAPEUTICS INC /DE/ with 1 ClinicalTrials.gov record(s).
Program details
- Company
- WINDTREE THERAPEUTICS INC /DE/
- Indication
- Respiratory Distress Syndrome, Newborn
- Phase
- Phase 2
- Modality
- other
- Status
- terminated